Biomarkers for community-acquired pneumonia in the emergency department (Q38263097)

1 September 2017

title

Biomarkers for community-acquired pneumonia in the emergency department (English)

1 reference

1 September 2017

0 references

0 references

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

7 June 2020

Lilliam Ambroggio

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

7 June 2020

author name string

Todd A Florin

series ordinal

1

1 reference

1 September 2017

Lilliam Ambroggio

series ordinal

2

1 reference

1 September 2017

publication date

1 December 2014

1 reference

Current infectious disease reports

1 September 2017

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

7 June 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

7 June 2020

issue

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

7 June 2020

page(s)

451

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25348745 AND SRC:MED&resulttype=core&format=json

Health care utilization for pneumonia in young children after routine pneumococcal conjugate vaccine use in the United States

7 June 2020

cites work

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Managing community-acquired pneumonia: a European perspective

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Infectious Diseases Society of America/American Thoracic Society Consensus Guidelines on the Management of Community-Acquired Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

The Management of Community-Acquired Pneumonia in Infants and Children Older Than 3 Months of Age: Clinical Practice Guidelines by the Pediatric Infectious Diseases Society and the Infectious Diseases Society of America

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Variation in emergency department diagnostic testing and disposition outcomes in pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Emergency department management of childhood pneumonia in the United States prior to publication of national guidelines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Variation in the use of chest radiography for pneumonia in pediatric emergency departments

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Processes of care, illness severity, and outcomes in the management of community-acquired pneumonia at academic hospitals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

A prediction rule to identify low-risk patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Is serum procalcitonin a reliable diagnostic marker in children with acute respiratory tract infections? A retrospective analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Serum procalcitonin, C-reactive protein and interleukin-6 for distinguishing bacterial and viral pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

A systematic review on the diagnosis of pediatric bacterial pneumonia: when gold is bronze

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic value of laboratory tests in identifying serious infections in febrile children: systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Utility of inflammatory markers in predicting the aetiology of pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin in children admitted to hospital with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Biomarkers: a definite plus in pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Differentiation of bacterial and viral pneumonia in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Can we predict pneumococcal bacteremia in patients with severe community-acquired pneumonia?

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Lack of usefulness of an abnormal white blood cell count for predicting a concurrent serious bacterial infection in infants and young children hospitalized with respiratory syncytial virus lower respiratory tract infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

C-reactive protein in pneumonia: let me try again

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin and C-reactive protein in hospitalized adult patients with community-acquired pneumonia or exacerbation of asthma or COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

C-reactive protein in simple community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Utility of C-reactive protein in assessing the disease severity and complications of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Comparison of usefulness of plasma procalcitonin and C-reactive protein measurements for estimation of severity in adults with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin, C-reactive protein and APACHE II score for risk evaluation in patients with severe pneumonia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

The complete sequence of human preprocalcitonin

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Clinical review 167: Procalcitonin and the calcitonin gene family of peptides in inflammation, infection, and sepsis: a journey from calcitonin back to its precursors

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Clinical review: the role of biomarkers in the diagnosis and management of community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic and prognostic accuracy of clinical and laboratory parameters in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Effect of procalcitonin-guided treatment on antibiotic use and outcome in lower respiratory tract infections: cluster-randomised, single-blinded intervention trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin Guidance of Antibiotic Therapy in Community-acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Effect of procalcitonin-based guidelines vs standard guidelines on antibiotic use in lower respiratory tract infections: the ProHOSP randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Interleukin-6 and procalcitonin as biomarkers in mortality prediction of hospitalized patients with community acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic value of procalcitonin, interleukin-6, and interleukin-8 in critically ill patients admitted with suspected sepsis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin as a marker of bacterial infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic value of procalcitonin in well-appearing young febrile infants.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Comparison of the test characteristics of procalcitonin to C-reactive protein and leukocytosis for the detection of serious bacterial infections in children presenting with fever without source: a systematic review and meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin and C-reactive protein as diagnostic markers of severe bacterial infections in febrile infants and children in the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Association of procalcitonin with acute pyelonephritis and renal scars in pediatric UTI.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin is more useful than C-reactive protein in differentiation of fever in patients with sickle cell disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin as a marker of bacteremia in children with fever and a central venous catheter presenting to the emergency department

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin, C-reactive protein and leukocyte count in children with lower respiratory tract infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Serum procalcitonin concentrations in bacterial pneumonia in children: a negative result in primary healthcare settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Human metapneumovirus pneumonia in children: results of an Italian study and mini-review

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Elevated inflammatory markers combined with positive pneumococcal urinary antigen are a good predictor of pneumococcal community-acquired pneumonia in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Seasonal patterns of viral and bacterial infections among children hospitalized with community-acquired pneumonia in a tropical region

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin measurements for guiding antibiotic treatment in pediatric pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin guidance to reduce antibiotic treatment of lower respiratory tract infection in children and adolescents (ProPAED): a randomized controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

A review of the biological properties and clinical implications of adrenomedullin and proadrenomedullin N-terminal 20 peptide (PAMP), hypotensive and vasodilating peptides

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Identification of an Adrenomedullin precursor fragment in plasma of sepsis patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397].

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Enhancement of CURB65 score with proadrenomedullin (CURB65-A) for outcome prediction in lower respiratory tract infections: derivation of a clinical algorithm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Midregional proadrenomedullin as a prognostic tool in community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Prognostic power of proadrenomedullin in community-acquired pneumonia is independent of aetiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Proadrenomedullin improves Risk of Early Admission to ICU score for predicting early severe community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Pro-adrenomedullin usefulness in the management of children with community-acquired pneumonia, a preliminar prospective observational study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic value of microscopic examination of Gram-stained sputum and sputum cultures in patients with bacteremic pneumococcal pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Laboratory methods for determining pneumonia etiology in children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Indirect effect of 7-valent pneumococcal conjugate vaccine on pneumococcal colonization among unvaccinated household members

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

The descriptive epidemiology of Streptococcus pneumoniae and Haemophilus influenzae nasopharyngeal carriage in children and adults in Kilifi district, Kenya

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Prevalence of bacteremia in hospitalized pediatric patients with community-acquired pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Evaluation and improvement of real-time PCR assays targeting lytA, ply, and psaA genes for detection of pneumococcal DNA.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnosis of pneumococcal pneumonia: current pitfalls and the way forward

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Classical and Latent Class Analysis Evaluation of Sputum Polymerase Chain Reaction and Urine Antigen Testing for Diagnosis of Pneumococcal Pneumonia in Adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Etiologic diagnosis of adult bacterial pneumonia by culture and PCR applied to respiratory tract samples

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Pneumococcal DNA is not detectable in the blood of healthy carrier children by real-time PCR targeting the lytA gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Epidemiology and clinical characteristics of community-acquired pneumonia in hospitalized children

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Severity of pneumococcal pneumonia associated with genomic bacterial load

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Diagnostic Tests for Agents of Community-Acquired Pneumonia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Rapid diagnosis of bacteremic pneumococcal infections in adults by using the Binax NOW Streptococcus pneumoniae urinary antigen test: a prospective, controlled clinical evaluation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Evaluation of a rapid urine antigen assay for the detection of invasive pneumococcal disease in children.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Gene expression patterns in blood leukocytes discriminate patients with acute infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Whole blood gene expression profiles to assess pathogenesis and disease severity in infants with respiratory syncytial virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Pneumococcal pneumonia: potential for diagnosis through a urinary metabolic profile.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007/S11908-014-0451-8

Procalcitonin increase in early identification of critically ill patients at high risk of mortality

21 January 2018

1 reference

12 December 2020

The utility of biomarkers in differentiating bacterial from non-bacterial lower respiratory tract infection in hospitalized children: difference of the diagnostic performance between acute pneumonia and bronchitis

1 reference

12 December 2020

Diagnosis of Legionella infection

1 reference

12 December 2020

Usefulness of the Streptococcus pneumoniae urinary antigen test in the treatment of community-acquired pneumonia

1 reference

12 December 2020

The utility of serum C-reactive protein in differentiating bacterial from nonbacterial pneumonia in children: a meta-analysis of 1230 children

1 reference

12 December 2020

Usefulness of real-time PCR for lytA, ply, and Spn9802 on plasma samples for the diagnosis of pneumococcal pneumonia

1 reference

12 December 2020

Diagnosis of Streptococcus pneumoniae lower respiratory infection in hospitalized children by culture, polymerase chain reaction, serological testing, and urinary antigen detection

1 reference

12 December 2020

Procalcitonin and its component peptides in systemic inflammation: immunochemical characterization

1 reference

12 December 2020

Calcitonin precursors are reliable markers of sepsis in a medical intensive care unit

1 reference

12 December 2020

Differentiation of bacterial and viral community-acquired pneumonia in children

1 reference

12 December 2020

Community-acquired pneumonia in Christchurch and Waikato 1999-2000: microbiology and epidemiology

1 reference

12 December 2020

White blood cells, C-reactive protein and erythrocyte sedimentation rate in pneumococcal pneumonia in children

1 reference

12 December 2020

Metabolomic analysis in severe childhood pneumonia in the Gambia, West Africa: findings from a pilot study

1 reference

12 December 2020

Increased circulating adrenomedullin, a novel vasodilatory peptide, in sepsis

1 reference

12 December 2020

Serum C-reactive protein cannot differentiate bacterial and viral aetiology of community-acquired pneumonia in children in primary healthcare settings

1 reference

12 December 2020

C-reactive protein is an independent predictor of severity in community-acquired pneumonia

1 reference

12 December 2020

Serum procalcitonin in pneumococcal pneumonia in children

1 reference

12 December 2020

Serum procalcitonin, adenosine deaminase and its isoenzymes in the aetiological diagnosis of pneumonia in children

1 reference

12 December 2020

1 reference

12 December 2020

Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia

1 reference

12 December 2020

Diagnostic value of the Binax NOW assay for identifying a pneumococcal etiology in patients with respiratory tract infection.

1 reference

12 December 2020

Procalcitonin and C-reactive protein levels in community-acquired pneumonia: correlation with etiology and prognosis

1 reference

12 December 2020

Utility of procalcitonin, C-reactive protein and white blood cells alone and in combination for the prediction of clinical outcomes in community-acquired pneumonia

1 reference

12 December 2020